23 November 2017
News and Views
Links and Services
The latest issue of the Inflammatory Bowel Diseases evaluates the impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease.
Infliximab is efficacious in the management of moderate to severe Crohn's disease.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors